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ABSTRACT
The Effect of Embryo Biopsy and Vitrification on the Development
Potential of Equine Embryos
Richard O. Gearhart

This study investigated the development potential of equine embryos
in vitro after biopsy and vitrification. Twenty embryos were obtained from
Quarter Horse, Thoroughbred, and mix-breed light mares between three and
ten years old. The twenty embryos were divided into a biopsy (n=10) and
control group (n=10). The biopsy group underwent microaspiration biopsy
using a micromanipulator to obtain a small tissue sample from the embryo.
Both groups were then vitrified using a commercially available technique
originally described by Carnevale (2006) at Colorado State University.
All 20 embryos were cultured in DMEM/Hams F-12 medium under
oil at 37°C in 5% CO2 in air (Hinrichs et al., 1990). Embryos were
monitored for expansion and hatching. Embryo development was
statistically different between the two groups (p<0.05). The biopsy
procedure did result in a much lower development potential in the biopsy
group as compared to the control group (20% vs. 80%). However, embryos
in the biopsy group did show expansion and hatching therefore the combined
procedure did not preclude development potential in vitro. Based on these
iv

findings, more research needs to be done to increase the success of the
combined procedure and the ultimate viability of the embryos needs to be
confirmed with the establishment of successful pregnancies.
Key Words: Vitrification, embryo biopsy, microaspiration,
micromanipulation, and embryo culture.
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Chapter 1
Literature Review

Introduction
Rationale
The development and use of embryo transfer in the horse has
progressed steadily and foals resulting from embryo transfer are now
permitted in most breed registries (Squires et al., 2003). However embryo
technologies in the horse have lagged behind that of other livestock species.
Several unique biological features as well as technical problems have limited
embryo technology advancement in the horse as compared to that of the
cattle industry (Squires, 1999). The lack of an effective superovulation
technique in the horse combined with a reluctance of some breed registries
to embrace newer embryo technologies has limited the development and
commercialization of techniques now considered to be commonplace in the
cattle industry. In vitro fertilization, intracytoplasmic sperm injection,
oocyte freezing, embryo biopsy, and embryo cryopreservation can still be
considered developing technologies in the horse (Squires et al., 2003).
It is likely that advancements will continue to be made in the future as
breed registry rules change and newer techniques are developed to allow
superovulation in the mare. It also seems sensible that the most economical
way of moving genetic material throughout the world is in a cryopreserved
state (Squires et al., 2003). The use of pre-implantation genetic diagnosis
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could be used to enhance the value of embryo cryopreservation and lead to
more successful commercialization of embryo technologies.
Preimplantation genetic testing would allow for the culling of embryos with
genetic mutations and the marketing of embryos known to result in foals of a
specific color or gender.
Purpose
The unique characteristics of equine embryo development make
equine embryo cryopreservation a labor intensive and expensive process.
The equine embryo forms a thin glycoprotein capsule as it expands into a
blastocyst. The capsule is resistant to cryoprotectants, therefore successful
equine embryo cryopreservation must be carried out prior to capsule
formation. This presents a problem unique to the horse as the equine embryo
normally passes from the oviduct into the uterus 5.5 days post ovulation and
the glycoprotein capsule begins to form 6.5 days post ovulation (Freeman et
al., 1991). The short duration between the arrival of the embryo in the uterus
and capsule formation presents a very narrow window of opportunity during
which the embryo can be collected and frozen. As embryos are collected
using non-surgical uterine lavage, mares must be monitored closely by
ultrasound to determine the time of ovulation. Even with close monitoring,
the expected number of embryos recovered is fewer than 1 per lavage.
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Because of the expense and low number of embryos recovered, equine
embryo cryopreservation is not economically viable and research for better
techniques has not resulted in success similar to other livestock species,
although an effective and commercially available vitrification process that
allows for quick cryopreservation of equine embryos without specialized
equipment has been developed (Carnevale, 2006).
Pre-implantation genetic diagnosis could add value to equine embryo
cryopreservation. If equine embryos could be genetically tested prior to
cryopreservation, it could confirm the resulting foal would be genetically
normal and even determine the potential foal’s gender and color. Genetic
tests are currently available to test for several inherited diseases commonly
found in various horse breeds including Hyperkalemic Periodic Paralysis
(HYPP) Disease, Glycogen Branching Enzyme Deficiency (GBED),
Junctional Epidermolysis Bullosa (JEB), and HERDA - Hereditary equine
regional dermal asthenia.
The purpose of this study is to determine if embryo biopsy performed
prior to cryopreservation will affect embryo viability in vitro.
Research Goals
The main goal of this study is to investigate the effect of embryo
biopsy and subsequent cryopreservation (vitrification) on the development
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potential of equine embryos. The working hypothesis tested in the study is
that combining vitrification and biopsy of equine embryos does not alter the
development potential of equine embryos in vitro.
The specific objectives are:
(1) To determine if embryo biopsy affects in vitro development of the
equine embryo.
(2) To determine if embryo biopsy and vitrification treatment
combined inhibits in vitro development of equine embryos more than
embryos treated by vitrification alone (no biopsy).
Demonstrating the potential for development in vitro of equine
embryos after combining the two techniques would help establish the
potential for further research in vivo.
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Embryo Technologies in the Horse
Although artificial insemination was probably used on the horse
before any other large animal species, it was the last to undergo embryo
recovery and transfer (Allen, 2005). The techniques of embryo collection
and transfer in horses were developed in the 1970’s (Squires et al., 2003).
The lag in further development of embryo technologies in the horse
compared to other livestock species is often blamed on the initial
unwillingness of breed registries to accept foals produced by embryo
transfer and the lack of an effective superovulation protocol for mares. In
addition, the first attempts at non-surgical embryo transfer had relatively low
success (Allen & Rowson, 1972; Squires et al., 1985). It appears as horse
producers discovered the potential commercial benefits of embryo
technologies, research increased. Great progress in the non-surgical
technique was made in the 1990s especially in Argentina where high value
polo ponies are produced (Pashen et al., 1993; Riera & McDonough, 1993).
Progress began to increase in America when the restrictions limiting the
number of offspring that could be registered as a result of embryo transfer
was lifted from the American Quarter Horse Registry (Hudson & McCue,
2004). Preimplantation genetic testing has the potential to increase the
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commercial appeal of embryo technologies even more and thus encourage
research.
Embryo Collection
The recovery of embryos from a donor mare is a straightforward
process. The relatively straight and easily distensible cervix of a mare make
it a simple process to pass a two-way catheter into the body of the uterus
(Allen, 2005). An inflatable cuff on the end of the catheter allows the
internal opening of the cervix to be sealed. An embryo-flushing medium is
then used to distend the uterus and dislodge the embryo. The medium is
recovered by gravity flow through an in-line embryo filter cup. The contents
of the filter cup is carefully searched under a microscope and the embryo
recovered. The direct transfer to a recipient mare is also a straightforward
procedure and with proper embryo handling can result in acceptable
pregnancy rates of 75%-85% (Pashen et al. 1993; Meadows
et al. 2000; Jasko 2002). However, the transfer of frozen equine embryos
presents some additional challenges.
Equine embryos take an unusually long time to pass from the oviduct
into the uterus (Allen, 2005). Because equine embryos remain in the oviduct
for 144 to 168 hours, most are collected 7 to 8 days post ovulation (Battut et
al., 2000). Multiple studies have shown that embryos greater than 300μm
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are unsuitable for cryopreservation (Squires et al., 2003). Blastocyst
formation and expansion begins 6-7 days post ovulation (Grondahl & Hytell,
1996). This creates a problem for collecting morula or early blastocyst
(<300μm) stages needed for successful cryopreservation. There is a very
narrow window of opportunity when the embryo is in the uterus, but is still
small enough for cryopreservation. Carnevale (2006) described a method to
increase the number of morulae and early blastocysts recovered smaller than
300μm by timing the flushes from ovulation induction. Ovulation occurs
approximately 36 hours after the administration of human chorionic
gonadotropin (hCG) and approximately 40 hours after administration of a
gonadotropin-releasing hormone (GnRH) analogue (deslorelin). Carnevale
(2006) demonstrated that embryo flushes can be carried out exactly eight
days from administration of an ovulation-inducing hormone to collect
embryos small enough for vitrification (<300m). But even with the
improved methods of embryo collection, the mean embryo recovery per
cycle is approximately 50% (Squires et al., 2003).
Superovulation
The failure of the mare and other equids to undergo genuine
superovulation in response to treatment with exogenous gonadotrophic
hormones has been a major limiting factor to the commercial development
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of equine embryo transfer from the outset (Allen, 2005). There are
numerous accounts of as many as 20-30 viable embryos from cattle, sheep,
and pigs from a single uterine flush when superovulation was induced.
Despite a commercial, partially purified extract of equine FSH being
available, the effectiveness remains disappointingly low. Alvarenga et al.
(2000) reported an improved embryo recovery of 3.5 embryos per cycle in
mares treated twice daily for 6-8 days with eFSH. However commercial
embryo recovery remains at a mean of just 1.8 per flush for treated mares
compared to a recovery of .85 embryos per cycle from non-treated donor
mares (Allen, 2005). While research is still being conducted on mare
ovarian stimulation, there appears to be a basic physiologic challenge to
superovulation. Allen (2005) notes that equine follicles can only ovulate
and release their oocytes through the ovulation fossa because of the very
tough and fibrous tunica albuginea covering the external surface of the
ovary. Even with increased follicle development, the number of embryos
recovered is low. According to Allen this implies that the follicles compete
with one another in their attempt to track through the ovary toward the
ovulation fossa. While it is possible to slightly increase the number of
ovulations per cycle, it still doesn’t approach the 20 embryos per cycle
demonstrated in other livestock species.
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With the low response to treatment with expensive hormones,
superovulation still is not commercially viable in the equine. Most embryo
recoveries in equids are performed on spontaneously ovulating mares
(Squires et al., 2003). The recovered embryos are then directly transferred
to recipient mares. In other livestock species, the number of recovered
embryos often exceeds the number of available recipients resulting in excess
embryos. With a lack of extra embryos in the equine, research on
cryopreservation and other embryo technologies has continued to be slow to
develop. Without the ability to produce large numbers of embryos through
superovulation, opportunities for research have also been limited.
Embryo Cryopreservation
Techniques for the transfer of frozen equine embryos have lagged
well behind that of bovine embyos mainly because of biological reasons
(Squires et al., 2003). Because of the lack of an effective superovulation
protocol in horses, typically only a single embryo is recovered and
immediately transferred to a recipient mare. However in bovine embryo
transfer, donor cattle often produce in excess of 20 embryos (Allen, 2005).
The number of embryos collected often exceeds the number of recipients
available. The lack of recipients created a need for embryo cryopreservation
research (Galli et al., 2003). According to Galli et al. (2003), large numbers
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of bovine embryos can also be produced using ovaries of slaughtered
donors. The ovaries are often pooled and processed as a batch. This
simplifies the process and consequently embryos are produced at low cost.
This gives researchers an abundant source of embryos.
Equine embryos also form a unique, thin glycoprotein capsule which
resists the penetration of cryoprotectants and makes the freezing of
blastocysts and expanded blastocysts very difficult (Legrand et al. 2000).
Squires et al., (2003) reported that several investigators have demonstrated
embryos <300μm in size (before the capsule forms) survive freezing and
thawing, whereas larger embryos have much lower survival rates.
A significant advance occurred in embryo freezing with the
application of vitrification (Allen, 2005). Vitrification is a process that uses
high concentrations of permeating cryoprotectants to flash freeze the
embryo. Damaging ice crystals do not form and instead a glass-like state is
achieved (Carnevale, 2006). Carnevale (2006) reported pregnancy rates of
60-75% when vitrifying embryos <300 μm diameter. Unlike conventional
embryo freezing, vitrification is a quick procedure that requires no special
equipment and can even be carried out in field conditions. Vitrified embryos
can be rapidly warmed within a straw and directly transferred into the uterus
of a donor mare (Carnevale, 2006).
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Embryo Culture
Hinrichs et al. (1990) were the first to describe equine embryo
development in long-term culture (10-20 days). The investigators recovered
morulae stage embryos via non-surgical lavage and placed them in culture
media. The embryos were maintained at 37°C in a 5% CO2 atmosphere.
The embryos expanded by the third day of culture and later hatched from
their zona, rather than the zona thinning and flaking off as occurs in vivo
(Hinrichs et al., 1990). According to Hinrichs et al. (1990), the results of
their study indicate that horse embryos can consistently maintain growth and
expansion for 10 days in vitro.
Embryo Biopsy
The use of embryo biopsy for pre-implantation genetic testing has
been around for quite some time in horses and other livestock species.
Huhtinen et al. (1997) were able to establish successful pregnancies that
resulted in live foals in 1994. The embryos were biopsied using a
microblade procedure removing 10-30 blastomeres from day 6 embryos
(Huhtinen et al., 1997). DNA from the biopsied cells was amplified using
polymerase chain reaction (PCR) to determine the resulting foals gender.
The pregnancy rate as reported by Huhtinen et al. (1997) was significantly
lower in the biopsy group (3/14) vs. the control group (6/8), but the authors
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pointed out that better biopsy techniques and earlier embryo recovery
(before the glycoprotein capsule formed) could potentially improve
pregnancy rates. The authors also noted that improved pregnancy results
along with more identified genes associated with particular diseases or
inherited characteristics could be used for preimplantation genetic
diagnostics (Huhtinen et al., 1997). A biopsy technique that utilized a
micro-needle to remove a smaller portion of the embryo was described by
Agca et al. in 1995. Embryos were held in place by suction applied to a
glass holding pipette. The pipette was controlled by a joystick-type
micromanipulator. An aspiration pipette was then inserted through the zona
pellucida and 2-3 blastomeres were removed by suction. The cells were left
in the media drop and later recovered for genetic testing (Agca et al., 1995).
PCR
Polymerase chain reaction (PCR) is a tool used to amplify specific
DNA sequences from minute quantities of cellular material. Using PCR,
genes have been identified from embryonic material of many species
(Huhtninen, et al. 1997). Successful DNA amplification has been carried
out on bovine and murine blastocysts (King & Wall, 1988), murine demimorulae (Ninomiya et al., 1990), bovine demi-blastocysts (Peura et al.,
1991), ovine 3-cell biopsies (Bredbacka & Peippo, 1992), equine demi-
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blastocysts (Huhtinen et al., 1997), and single blastomeres from human
(Verlinsky et al., 1991) and bovine (Machaty et al., 1993) embryos.
Genetic Testing
The American Association of Equine Practitioners (AAEP) supports
the use of genetic testing by veterinarians or breed associations to identify
genetic mutations in animals so that owners can make informed decisions
about breeding, purchase and specific treatments (American Association of
Equine Practitioners, 2009). According to the association, there are genetic
tests for 9 diseases.
Autosomal Dominant Diseases
1. Hyperkalemic Periodic Paralysis (HYPP) in the Quarter Horse
2. Type 1 Polysaccharide Storage Myopathy (PSSM) in numerous
breeds
3. Malignant Hyperthermia in Quarter Horse related breeds
Autosomal Recessive Diseases
4. Overo Lethal White Syndrome in the Paint Horse
5. Combined immunodeficiency in Arabian Horses
6. Glycogen Branching Enzyme Deficiency (GBED) in Quarter Horse
related breeds
7. Junctional Epidermolysis Bullosa (JEB) in Belgians
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8. JEB in Saddlebred horses
9. Hereditary Equine Regional dermal Asthemia (HERDA) in Quarter
Horse related breeds
AAEP also notes that there are numerous other conditions strongly
suspected to be due to mutations in genes of major effect, but genetic tests
are not yet available. Genetic testing for all of these diseases could also be
presumably carried out on single blastomeres using the PCR amplification
technique. In addition, there are tests for coat color genetics and gender.
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Chapter 2
Materials and Methods
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Embryo Collection
Embryos were obtained between February and September during the
regular breeding season from Quarter Horse, Thoroughbred, and mix-breed
light mares between three and ten years old. Mares and stallions underwent
reproductive evaluation to ensure fertility before being included in the study.
Follicular growth was monitored daily via transrectal palpation and
ultrasonography. Mares with follicles >35 mm were bred via artificial
insemination with fresh semen collected from Quarter Horse and Welsh
stallions. After insemination, mares were injected with hCG (2500 IU
administered IV) or deslorelin (1.5mg IM). Mares were monitored via
transrectal ultrasonography at 24 and 48 hours post insemination to confirm
ovulation.
Mares were re-checked via ultrasound 5 days post ovulation. If the
mares appeared free of fluid and uterine edema, they were flushed via nonsurgical, trans-cervical uterine lavage 6.0-6.5 days post-ovulation. Sedation
was provided prior to embryo recovery using 0.5mg/kg zylazine
administered intravenously. An embryo catheter with a 60-75cc balloon was
attached to Y tubing and inserted transcervically into the uterine body of the
mare. The balloon was inflated to capacity with flush media to seal the
cervix and mild pressure was applied in a caudal direction to seat the
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catheter against the internal cervical os. Four 1L increments of flush media
(BioLife Advantage Complete Flush Media, Agtech, Inc., Manhattan, KS)
were used to flush the uterus. Fluid was collected as it exited the uterus in a
cup with a 75-micron filter. After the flush was complete, 20 ml of flush
media was allowed to remain in the cup. The cup was then rinsed with
additional flush media into a search dish.
Embryo Identification
The dish was examined under a microscope at 10x power. Embryos
were identified by developmental stage and grade (Table 1). Once
identified, embryos were washed four times through embryo holding media
(Vigro Holding and Transfer Medium, Bioniche Animal Health USA Inc.,
Pullman, WA).
The embryos were temporarily placed in holding media in a 2ml
cryotube and held at room temperature for transport to the laboratory. Total
time from identification to treatment was less than 1 hour.
Biopsy and Vitrification
Embryos underwent micromanipulation and biopsy prior to being
cryopreserved. Embryos were placed in biopsy media (Embryo Biopsy
Medium, Irvine Scientific, Santa Ana, CA) under oil and viewed under a
microscope at 20x power. A small amount of tissue was removed from each
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embryo using a microaspiration technique. Embryos were held in position
by gentle suction from a holding pipette using a micromanipulator. A small
hole was mechanically made in the zona pellucida using a second
micromanipulator and a microneedle. A small amount of tissue was gently
aspirated and placed in the media near the embryo for later removal (Fig. 1).
Once the biopsy procedure was complete, the tissue samples were frozen in
1ml cryotrubes and stored at -20°C.
The biopsied embryos and control embryos (embryos not undergoing
biopsy) were then vitrified according to the protocol described by Carnevale
and co-workers (2006) at Colorado State University. During the vitrification
procedure, embryos are sequentially moved through three vitrification
solutions containing various combinations of glycerol and ethylene glycol as
cryoprotectants. To facilitate movement of the embryos from one
vitrification solution to the next and the rapid loading of the freezing straw,
the vitrification and diluent solutions can be set up on the lid of a Petri dish
(Fig. 2). A timer is necessary to ensure the proper exposure time to each of
the three vitrification solutions. Embryos are removed from the biopsy
media and placed into vitrification solution 1 (glycerol [1.4 M]). Movement
of the embryo is made with a small volume of media (<1L) to ensure the
embryo is exposed to the proper concentration of cryoprotectants. The

19

embryo remains in vitrification solution 1 for 5 minutes and then promptly
moved to vitrification solution 2 (glycerol [1.4 M] plus ethylene glycol [3.6
M]) for 5 minutes. The embryo is then placed in vitrification solution 3
(glycerol [3.4 M] plus ethylene glycol [4.6 M]). The embryo is exposed to
vitrification solution 3 for less than 1 minute before being placed in liquid
nitrogen vapor. To facilitate rapid loading of the freezing straw, the embryo
is placed in a 30L drop of vitrification solution 3, the exact amount to be
drawn up into the straw (Carnevale, 2006).
A 0.25-ml semen straw (nonirradiated, polyvinyl chloride) is loaded
with the embryo in the final vitrification solution between two sections of 90
-L of diluent solution (galactose; 0.5M) to allow dilution of cryoprotectants
in the straw after warming (Fig. 2). The straw is loaded for vitrification with
90 L galactose, air (5 L), the embryo in vitrification solution 3 (30 L),
air (5 L), and 90 L galactose. The straw is then sealed with a heat sealer
and placed in liquid nitrogen vapor (Carnevale, 2006). No special
equipment is required for vitrification; the straw containing the embryo is
exposed to vapor for 1 minute before plunging it into liquid nitrogen.
Embryos were stored in liquid nitrogen until thawing and culture.
Embryo Thawing
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Warming of the straw requires no special equipment. Biopsied and
control embryos were warmed within the straw. The straw was held in the
air for 10 seconds and then plunged in water (37° C) for 10 seconds. The
straw was then shaken to mix the contents (Carnevale, 2006). The contents
of the straw including the embryo were expelled into holding media (BioLife
Holding and Transfer Medium, Agtech, Inc., Manhattan, KS).
Embryo Culture
The embryos were identified and then transferred to a 200-μl droplet
of culture media (HyClone HyQ DMEM/Ham’s F-12 medium 1:1, Fisher
Scientific, Pittsburgh, PA) supplemented with 10% fetal calf serum and 100
mcg penicillin and 100 mcg streptomycin per ml, in a 35 mm petri dish
under a film of filtered paraffin oil. The culture technique used in this study
was described by Hinrichs et. al (1990). Embryos were incubated at
37°C in a humidified atmosphere of 5% CO2 in air. The medium was not
changed during the culture period. Using a dissection microscope at 10-50x
power, embryos were evaluated for normal development daily for 5 – 10
days of culture (until the embryos stopped expanding or degenerated).
Embryo morphology was recorded. Embryo viability could not be assessed
as no pregnancies were established, however development potential was
defined as blastocele expansion with thinning of the zona pellucida (Fig. 3).
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According to Hinrichs (personal communication 2006) evidence of
expansion (increase in diameter) especially with hatching from the zona
should be sufficient to prove that the embryos survive vitrification and thus
have development potential.
Statistical Analysis
The development potential of the study group (biopsy combined with
vitrification) was compared to the development potential of the control
group (vitrification only) using a chi-square goodness of fit test.
The statistical model used was:
2 =  [ (Oi - Ei)2 / Ei ]
where Oi is the observed frequency count for the ith level of the categorical
variable, and Ei is the expected frequency count for the ith level of the
categorical variable. For this study, the significance level is 0.05.
Carnevale et al. (2004) reported that 75% of vitrified embryos
<300m resulted in established pregnancies. Therefore, more than 75% of
the vitrified embryos in this study should show development potential.
Hypothesis:
H0: The development potential of the vitrification only group and the
development potential of the vitrification and biopsy group is at least
80%.
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Ha: The development potential of the vitrification and biopsy group is
less than the development potential of the vitrification only group.
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Chapter 3
Results
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Embryo Collection
Embryos (<300μm) were recovered from 20 of 43 flushes (47%)
including one set of multiple embryos. All embryos were classed
morphologically as excellent (15/20) or good (5/20) (grade 1 or 2) (Table 1;
Fig. 3). The embryos were sequentially assigned to either the biopsy or
control group.
Embryo Development
Embryos were monitored daily for development potential; defined as
expansion of the blastocele, thinning of the zona pellucide and in some cases
hatching from the zona pellucida (personal communication Hinrichs, 2006).
Although equine embryos do not hatch from the zona like other species in
vivo, the embryos do hatch when cultured in vitro (Hinrichs et al., 1990).
The embryos that did show development potential had developed a
well defined blastocele by day 3 in culture and those that hatched had either
partially or completely broken free of the zona pellucida by day 5 in culture.
None of the embryos showed any further development after 5 days in
culture. Figure 4 shows an example of the incomplete hatching of an
embryo after vitrification and culture in vitro. Figure 5 shows the complete
hatching of the embryo. Once free of the zona pellucida, the blastocyst
expanded quite rapidly until it degenerated on day 5 in culture. While
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hatching was common, there were examples of embryos that showed
noticeable expansion and thinning of the zona pellucida, but without
hatching (Fig. 6).
The embryos with no development potential showed no signs of
expansion or zona pellucida thinning during culture. Figure 7 is an example
of an embryo that did not increase in diameter and showed more
degeneration of the blastomeres while in culture.
The embryos that underwent the combined vitrification and biopsy
treatment were much less likely to show expansion and hatching, but those
that did typically showed hatching through the zona tear created during the
biopsy process. Figure 8 is a biopsy embryo that hatched through the zona
tear. Two of the embryos in the combined treatment were not intact after
thawing. Neither embryo showed any kind of subsequent development
while in culture. Figure 9 is an example of an embryo without a defined
zona pellucida after thawing.
None of the embryos in this study was transferred to a recipient and
thus no pregnancies were established.
Statistical Findings
There was a statistically significant difference (P<0.05) between the
development potential of the biopsy group (2/10 embryos) compared to the
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control group (8/10 embryos) (Table 2). While the development of the
embryos was significantly different than the control group, it was not zero.
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Equine embryo transfer was developed in the 1970s (Squires et
al., 2003). Since then, researchers have been able to establish successful
pregnancies after biopsy (Huhtinen et al., 1997), culture equine embryos
before transfer (Weimer et al., 1989), and develop a commercially available
vitrification method (Carnevale, 2006). What has not been accomplished is
combining biopsy with vitrification. The combined procedure is important
because any genetic testing of the embryo should be carried out before
transfer to a recipient.
This study looked at embryo development in vitro after biopsy and
vitrification as a combined procedure. Because the embryos were not
transferred to a recipient mare and no pregnancies were established, it did
not determine the ultimate viability of the embryos after the combined
procedures. Instead this study determined development potential in vitro.
Culturing the embryos in vitro eliminates variables with the embryo transfer
process itself. It is important to establish whether embryos can survive the
combined procedure before attempting to establish pregnancies. Failure to
establish successful pregnancies could be the result of the transfer process
itself, rather than the biopsy/vitrification procedures. Because Hinrichs and
co-workers (1990) showed that equine embryos do develop in vitro, this
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study was able to determine whether the combined procedure affected
embryo survivability in vitro.
Although growth and hatching rates were much lower in comparison
to the control group, the results do show that equine embryos can grow in
vitro after undergoing biopsy and vitrification together thus it does not
preclude the potential to establish successful pregnancies after the combined
procedures. It does however point to the need for further research to refine
the combined procedure.
Because both vitrification and biopsy are established procedures
separately, the lower success rates achieved in the treatment group can be
attributed to the combination of the two. The biopsy procedure requires
creating a small tear in the zona pellucida. The resulting tear creates an
opening that may affect how cryoprotectants interact with the embryo.
Changes to the vitrification procedure may be needed. Different vitrification
solution concentrations or a change in the exposure times may lead to
greater success in the future.
The biopsy procedure may be damaging the embryo. The two
embryos that showed expansion and hatching after the combined procedures
were the last two to undergo micromanipulation. Technician experience has
been shown to affect pregnancy rates after non-surgical embryo transfer in
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the horse (Iuliano et al., 1985). Technician experience with the
micromanipulation procedure could have affected success in this study as
well.
Embryos had to be transported from the collection location to the lab.
Carnevale (2006) recommends vitrification procedures be carried out as
quickly as possible. The transport time combined with the time required for
the biopsy procedure may have affected embryo survivability. Reducing the
time between collection and vitrification enhance development potential.
Research in equine intracytoplasmic sperm injection (ICSI) has shown
that the use of a piezo drill improves cleavage rates (Hinrichs, 2005). The
device causes minute vibrations in the injection pipette facilitating passage
through the zona pellucida (Hinrichs, 2005). The same technology could
improve success rates with the microaspiration technique. The technique
used in this study requires pressure on the embryo to tear a small opening in
the zona pellucida. The piezo drill makes smaller opening while exposing
the embryo to less pressure (Hinrichs, 2005).
Due to budget limitations and limited facilities, this study included a
small number of equine embryos. A larger sample size may have provided a
more accurate assessment of the development potential of embryos after the
combined procedure.
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Implications
Because this study did not preclude in vitro development of equine
embryos after biopsy and vitrification, it shows promise for the eventual
development of a preimplantation genetic diagnosis technique for horses.
The ability to ensure that embryos are free from known genetic mutations
would increase the value of embryo transfer and embryo cryopreservation to
breeders. Predetermining the gender and color of potential offspring could
also make the embryos more valuable.
However, to take advantage of the genetic testing available, it would
need to be carried out prior to pregnancies being established. The ability to
biopsy and genetically test the embryo is not practical unless the embryo can
be stored while the testing is conducted. This study lays the groundwork for
the ability to store embryos that have undergone biopsy. While Hinrichs and
co-workers are carrying out a similar study at Texas A & M University, no
known published research exists on combining vitrification and biopsy in the
equine embryo.
Embryo technologies in the horse lag behind that of other livestock
(Allen, 2005). Much of this can be blamed on the lack of available equine
embryos for research. The lack of an effective superovulation protocol
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means that there are very few extra embryos available. Typically a single
embryo is collected from a donor mare and immediately transferred to a
recipient. Adding value to the embryo transfer procedure could lead to
additional research. The ability to eliminate known genetic mutations by
culling embryos before transfer would add value for breeders. Embryos with
genetic mutations could be eliminated from storage before being transferred
to a recipient. Additionally, the ability to predetermine the genetic health,
gender and coat color of embryos could add value for the potential
import/export of equine embryos. Increasing the value of embryo
cryopreservation would open the door to further research in superovulation
and other embryo technologies in the horse.
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Tables
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Table 1. System used to grade the quality of equine embryos*

Grade 1

Excellent or good: Symmetrical and spherical embryo
mass with cells of uniform size, color, and density.
Embryo mass has clear edges without indentation. No
evidence of cellular fragmentation or loose
cytoplasmic granules in the perivitelline space.

Grade 2

Fair: Moderate irregularities in the overall shape of the
embryo, for example, a minor degree of cytoplasmic
fragmentation evident as slight convolution of the
edges of the embryo and small cytoplasmic granules
in the perivitelline space.

Grade 3

Poor: Major irregularities in the shape of the embryonic
mass or in the size, color, or density of the constituent
cells. High degree of cytoplasmic fragmentation with
extrusion or degeneration of cells of variable size
reflected by highly lobulated, irregular edges of the
embryonic mass and a large perivitelline space.

Grade 4

Degenerate or dead: High degree of cytoplasmic
fragmentation. Embryonic cells of irregular size and
color. Absence of cellular compaction and failure to
form a clear embryonic mass. This group includes
embryos with irregularly sized cells of a low number
inconsistent with the expected stage of development.

* Tremoleda et al., 2003
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Table 2. Chi-Square Goodness-of-Fit Test for Observed Counts
Historical
Test
Contribution
Category Observed
Counts
Proportion Expected
to Chi-Sq
1
8
8
0.4
8
0.0
2
2
2
0.1
2
0.0
3
2
8
0.4
8
4.5
4
8
2
0.1
2
18.0
N
DF
Chi-Sq
P-Value
20
3
22.5
P<0.05
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A.

B.

C.

D.
Figure 1. Microaspiration biopsy technique. The embryo is placed on a
holding pipette (A). A small hole is created in the zona pellucida with the
biopsy needle (B). Gentle suction is applied to aspirate a small amount of
tissue (C). The tissue sample is released next to the embryo for later
retrieval (D).
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Figure 2. Organization of the vitrification solutions and diluent solution in a
petri dish. Volumes of vitrification solutions 1 & 2 (VS 1; VS 2) can be
approximate; however, precise amounts are needed of vitrification solution 3
(VS 3) and the diluent solution (DS) when loading the straw (Carnevale,
2006).
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A.

B.

C.

D.

Figure 3. Examples of embryos before treatment and their morphological
assessment. Morula grade 1(A). Morula grade 2 (B). Early blastocyst
grade 1 (C). Expanding blastocyst grade 2 (D).
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A.

B.

C.

D.

Figure 4. An example of the expansion and hatching seen during in vitro
culture. This embryo was vitrified without biopsy. The embryo is a very
early blastocyst with only a small blastocele visible after thawing (A). By
day 2, the embryo shows significant re-expansion (B). A small hole has
formed in the zona pellucida by day 3 (C). Almost complete hatching by
day 5 (D).
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A.

B.

C.

D.

Figure 5. Embryos that hatched earlier expanded to a much greater size
before degenerating. This morula (vitrification without biopsy) showed
some blastomere contraction upon thawing (A), but quickly re-expanded and
completely hatched by day 3 in culture (B). The empty zona pellucida was
visible right next to the expanded blastocyst (C). Without the glycoprotein
capsule, the blastocyst rapidly expanded (D).
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A.

B.

C.

D.

Figure 6. Some of the embryos showed blastocele expansion and thinning of
the zona pellucida without hatching. This morula (vitrification without
biopsy) show a great deal of contraction of the blastomeres upon thawing
(A). By day 3 a blastocele had developed with thinning of the zona
pellucida (B). On day 4, even greater expansion and zona thinning occurred
(C), but complete degeneration was seen on day 5 (D).
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Biopsy tear

A.

B.

C.

D.

Figure 7. Embryos without developmental potential showed no expansion
during in vitro culture. This embryo (biopsy with vitrification) was a grade
1 morula but showed considerable degeneration upon thawing and the tear in
the zona pellucida as a result of the biopsy procedure can be clearly seen(A).
Even greater degeneration can be seen by day 3 (B), day 4 (C), and day 5
(D) with no zona thinning or embryo expansion.
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A.

B.

C.

D.

Figure 8. The embryos that underwent both biopsy and vitrification hatched
through the opening created in the zona pellucida by the biopsy procedure.
This embryo (biopsy with vitrification) was a grade 1 morula that showed
some degeneration upon thawing (A). By day 2, it had expanded to a small
blastocyst (B). By day 3, greater expansion and zona pellucida thinning was
evident (C). Incomplete hatching could be seen by day 5 (D).
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A.

B.

Figure 9. This embryo did not survive the vitrification with biopsy
procedure. At thaw, the embryo was degenerated with no evidence of an
intact zona pellucida (A). It continued to degenerate through day 5 in
culture (B).
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